GYRE:NASDAQ, Gyre Therapeutics, Inc.

GYRE stock overview

Gyre Therapeutics, Inc. (GYRE:NASDAQ) closed at $4.21 on November 20, 2026, down 6.86% on the day. The stock trades 53.9% below its 52-week high of $9.14 and 6.0% above its 52-week low of $3.97. Over the past year, it lost 46.5%. Gyre Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$4.21
Day change
-6.86%
Volume
240,136
Average volume
178,321
Market cap
460M+
52-week range
$3.97 – $9.14
50-day average
$6.10
200-day average
$6.74

Price action over the past year

In 252 trading sessions since November 20, 2025, GYRE closed higher on 114 days (45%). Its best day was November 6, 2026 (+18.70%) and its worst was October 30, 2026 (-28.86%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

GYRE news

About Gyre Therapeutics, Inc.

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.

Similar stocks

Find more stocks like GYRE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.